Literature DB >> 31118242

Bipolar disorder and risk of Parkinson disease: A nationwide longitudinal study.

Mao-Hsuan Huang1, Chih-Ming Cheng2, Kai-Lin Huang1, Ju-Wei Hsu1, Ya-Mei Bai1, Tung-Ping Su1, Cheng-Ta Li1, Shih-Jen Tsai1, Wei-Chen Lin1, Tzeng-Ji Chen1, Mu-Hong Chen2.   

Abstract

OBJECTIVE: To evaluate the risk of Parkinson disease (PD) among patients with bipolar disorder (BD).
METHODS: Using the Taiwan National Health Insurance Research Database, we examined 56,340 patients with BD and 225,360 age- and sex-matched controls between 2001 and 2009 and followed them to the end of 2011. Individuals who developed PD during the follow-up period were identified.
RESULTS: Patients with BD had a higher incidence of PD (0.7% vs 0.1%, p < 0.001) during the follow-up period than the controls. A Cox regression analysis with adjustments for demographic data and medical comorbid conditions revealed that patients with BD were more likely to develop PD (hazard ratio [HR] 6.78, 95% confidence interval [CI] 5.74-8.02) than the control group. Sensitivity analyses after exclusion of the first year (HR 5.82, 95% CI 4.89-6.93) or first 3 years (HR 4.42; 95% CI 3.63-5.37) of observation showed consistent findings. Moreover, a high frequency of psychiatric admission for manic/mixed and depressive episodes was associated with an increased risk of developing PD.
CONCLUSION: Patients with BD had a higher incidence of PD during the follow-up period than the control group. Manic/mixed and depressive episodes were associated with an elevated likelihood of developing PD. Further studies are necessary to investigate the underlying pathophysiology between BD and PD.
© 2019 American Academy of Neurology.

Entities:  

Year:  2019        PMID: 31118242     DOI: 10.1212/WNL.0000000000007649

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Risk of Developing Parkinson Disease in Bipolar Disorder: A Systematic Review and Meta-analysis.

Authors:  Patrícia R Faustino; Gonçalo S Duarte; Inês Chendo; Ana Castro Caldas; Sofia Reimão; Ricardo M Fernandes; José Vale; Michele Tinazzi; Kailash Bhatia; Joaquim J Ferreira
Journal:  JAMA Neurol       Date:  2020-02-01       Impact factor: 18.302

Review 2.  Na+ leak-current channel (NALCN) at the junction of motor and neuropsychiatric symptoms in Parkinson's disease.

Authors:  Merve Kasap; Donard S Dwyer
Journal:  J Neural Transm (Vienna)       Date:  2021-05-07       Impact factor: 3.575

3.  Astroglial Serotonin Receptors as the Central Target of Classic Antidepressants.

Authors:  Alexei Verkhratsky; Vladimir Parpura; Caterina Scuderi; Baoman Li
Journal:  Adv Neurobiol       Date:  2021

4.  Bioinformatics Approach to Identify Significant Biomarkers, Drug Targets Shared Between Parkinson's Disease and Bipolar Disorder: A Pilot Study.

Authors:  Md Bipul Hossain; Md Kobirul Islam; Apurba Adhikary; Abidur Rahaman; Md Zahidul Islam
Journal:  Bioinform Biol Insights       Date:  2022-02-23

5.  Preexisting Bipolar Disorder Influences the Subsequent Phenotype of Parkinson's Disease.

Authors:  Marco Onofrj; Angelo Di Iorio; Claudia Carrarini; Mirella Russo; Raffaella Franciotti; Alberto J Espay; Laura S Boylan; John-Paul Taylor; Massimo Di Giannantonio; Giovanni Martinotti; Enza M Valente; Astrid Thomas; Laura Bonanni; Stefano Delli Pizzi; Fedele Dono; StefanoL Sensi
Journal:  Mov Disord       Date:  2021-08-24       Impact factor: 9.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.